Cd99 as target/marker for insulin resistance

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/566 (2006.01)

Patent

CA 2589135

The present invention relates to the monitoring of disease progression and diagnosis of Insulin Resistance in diabetes by measuring levels of CD99 in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.

La présente invention concerne le suivi de la progression de la maladie et le diagnostic de la résistance insulinique du diabète par la mesure des niveaux de CD99 dans un prélèvement de liquide, et le classement des nouveaux composés destinés à la prévention et/ou au traitement du diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cd99 as target/marker for insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cd99 as target/marker for insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd99 as target/marker for insulin resistance will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1936336

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.